“There is a worrying trend of skipping over any science on MHT that isn’t pro-estrogen, and I believe it is because menopause influencers, companies like MIDI Health and Inner Balance, and even the press have tapped into the grievance economy, which profits by amplifying complaints about an issue and then presenting a surefire solution. In this case, everything that women over age 40 are facing is incorrectly reframed as not only being menopause, but related to the Women’s Health Initiative. And while it is true that many women did not get menopausal hormone therapy who could have benefitted, MHT is also not the answer to everything; we do not have good evidence that the decline in MHT prescribing after WHI caused an increase in cardiovascular deaths or dementia.”

No one does a better job of clarifying the difference between marketing messages and science than Jen Gunter, MD. This new post on her blog, The Vagenda is a valuable contribution to this conversation.,

An article in The Guardian dealing with prescription of menopausal hormone therapy contributed to a controversy about whether women have been unjustly denied appropriate care. Jen Gunter was recommended as a reliable source of information in the article, and she wrote this informative piece posted on her website “The Vagenda.”

Action on Smoking and Health organizes webinars regularly to inform stakeholders and activists about policy initiatives related to ending tobacco consumption globally.

Menstruation tracking is a valuable tool for women, including those with bleeding disorders, but experts say you need to be vigilant about what information you share.

This 2026 Oscar®-Nominated Short Film satire on Jane Austen‘s Pride and Prejudice is delightful. You can watch it here.

Omer’s petition argues that taxation on menstrual hygiene products is illegal because it treats a basic need as a luxury item, it reinforces gender inequality, and it punishes women simply for being women.